Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Publications (10 of 67) Show all publications
Schandl, A., Bergström, L., Selg, J., Eliasson, A., Hylèn, M., Silfwerbrand, F., . . . Hägglund, P. (2025). Identifying dysphagia in the intensive care unit: validation of the Swedish version of the gugging swallowing screen—intensive care unit. Acta Anaesthesiologica Scandinavica, 69(5), Article ID e70031.
Open this publication in new window or tab >>Identifying dysphagia in the intensive care unit: validation of the Swedish version of the gugging swallowing screen—intensive care unit
Show others...
2025 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 69, no 5, article id e70031Article in journal (Refereed) Published
Abstract [en]

Background: Dysphagia is independently associated with adverse outcomes in intensive care units (ICU). Early identification through dysphagia screening does not occur routinely, negatively impacting optimal patient management. This study aimed to validate the Swedish version of the Gugging Swallowing Screen—Intensive Care Unit (GUSS-IVA).

Methods: This is a prospective multicentre study of 56 adult ICU patients with endotracheal intubation exceeding 48 h at three hospitals in Sweden. The GUSS-ICU was translated into Swedish (GUSS-IVA) and used to screen all prolonged intubated patients (>48 h) once extubated. The GUSS-IVA screen was conducted by ICU nursing staff and then compared with a gold standard Flexible Endoscopic Evaluation of Swallowing (FEES) within 2 h of the GUSS-IVA screen. Fifty-one of 56 patients underwent FEES (where assessors were blinded to the GUSS-IVA screen results). Sensitivity and specificity were calculated, as was the area under the receiver operating characteristic curves (AUC) with 95% confidence intervals (CI). For inter-rater reliability, within 2 h of the initial screen, 29/56 patients were GUSS-IVA screened a second time by a nursing staff blinded to the first GUSS-IVA results.

Results: Among the 56 patients, 38 (67.9%) were identified as dysphagic using the GUSS-IVA screen. With FEES, 42 of 51 patients (82.4%) were diagnosed with dysphagia; of these, 16 (31.4%) were classified as aspirating. Compared to FEES, GUSS-IVA showed high sensitivity and specificity values (81% and 89%, respectively) with an AUC of 0.85 (95% CI: 0.71–0.95) and a positive predictive value of 97%. High convergent validity was obtained for GUSS-IVA compared with the Dysphagia Outcome Severity Scale (ɸ = 0.57, p <.001) and the Functional Oral Intake Scale (ɸ = 0.52, p <.001) and moderate validity with the Penetration-Aspiration Scale (ɸ = 0.30, p =.033). The inter-rater reliability showed moderate agreement (Cohen's kappa κ = 0.501, p =.006).

Conclusions: This study indicates that the Swedish GUSS-IVA is a valid and reliable screen to identify dysphagic ICU patients. Given the negative impact of dysphagia on short and long-term patient outcomes, the Swedish GUSS-IVA is recommended as an essential first step by nursing staff for early identification of dysphagia for further diagnostics and subsequent patient management.

Place, publisher, year, edition, pages
John Wiley & Sons, 2025
Keywords
aspiration pneumonia, critical care, critical illness, oropharyngeal dysphagia
National Category
Anesthesiology and Intensive Care Nursing
Identifiers
urn:nbn:se:umu:diva-237760 (URN)10.1111/aas.70031 (DOI)001454360800001 ()40143827 (PubMedID)2-s2.0-105001676444 (Scopus ID)
Funder
Region Västerbotten, RV-969268
Available from: 2025-04-30 Created: 2025-04-30 Last updated: 2025-04-30Bibliographically approved
Bader, S. E., Brorsson, C., Löfgren, N., Löfgren, F., Blind, P.-J., Sundström, N., . . . Olivecrona, M. (2024). Cerebral haemodynamics and intracranial pressure during haemorrhagic shock and resuscitation with total endovascular balloon occlusion of the aorta in an animal model. European Journal of Trauma and Emergency Surgery, 50(6), 3069-3082
Open this publication in new window or tab >>Cerebral haemodynamics and intracranial pressure during haemorrhagic shock and resuscitation with total endovascular balloon occlusion of the aorta in an animal model
Show others...
2024 (English)In: European Journal of Trauma and Emergency Surgery, ISSN 1863-9933, E-ISSN 1863-9941, Vol. 50, no 6, p. 3069-3082Article in journal (Refereed) Published
Abstract [en]

Purpose: To assess changes of cerebral haemodynamic and intracranial pressure (ICP) in animals, with or without elevated ICP, during controlled haemorrhagic shock and resuscitation with Total REBOA (tREBOA).

Method: In 22 anaesthetized and normoventilated pigs, after placement of catheters for monitoring invasive proximal blood pressure (pMAP), ICP, and vital parameters, and 60 min stabilisation phase, a controlled haemorrhagic shock (HS), was conducted. In 11 pigs (EICPG), an elevated ICP of 25–30 mmHg at the end HS was achieved by simulating an epidural mass. In 11 pigs (NICPG), the ICP was normal. tREBOA was then applied for 120 min. The changes of pMAP and ICP were followed, and cerebral perfusion pressure (CPP) calculated. The integrity of the autoregulation was estimated using a calculated Modified-Long Pressure Reactivity Index (mL-PRx).

Results: After stabilisation, hemodynamics and physiological parameters were similar and normal in both groups. At the end of the HS, ICP was 16 mmHg in NICPG vs. 32 in EICPG (p = 0.0010). CPP was 30 mmHg in NICPG vs. 6 mmHg in EICPG (p = 0.0254). After aorta occlusion CPP increased immediately in both groups reaching after 15 min up to104 mmHg in NICPG vs. 126 mmHg in EICPG. Cerebrovascular reactivity seems to be altered during bleeding and occlusion phases in both groups with positive mL-PRx. The alteration was more pronounced in EICPG, but reversible in both groups.

Conclusion: tREBOA is lifesaving by restoration the cerebral circulation defined as CPP in animals with HS with normal or elevated ICP. Despite the observation of short episodes of cerebral autoregulation impairment during the occlusion, mainly in EICPG, tREBOA seems to be an effective tool for improving cerebral perfusion in HS that extends the crucial early window sometimes known as the “golden hour” for resuscitation even after a traumatic brain injury.

Place, publisher, year, edition, pages
Springer Nature, 2024
Keywords
Cerebral autoregulation, Haemorrhagic shock, ICP, REBOA, Resuscitative endovascular balloon occlusion of the aorta
National Category
Anesthesiology and Intensive Care Surgery
Identifiers
urn:nbn:se:umu:diva-231382 (URN)10.1007/s00068-024-02646-0 (DOI)001341139300001 ()39453469 (PubMedID)2-s2.0-85207360385 (Scopus ID)
Funder
Region Västerbotten, RV969834 (2021-10-11)Region Västerbotten, RV- 941769 (2020-10-10)Region Västerbotten, RV-849041 (2018- 10-07)
Available from: 2024-11-12 Created: 2024-11-12 Last updated: 2025-03-20Bibliographically approved
Granvik, C., Andersson, S., Andersson, L., Brorsson, C., Forsell, M. N. E., Ahlm, C., . . . Edin, A. (2024). Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up. Brain and Behavior, 14(6), Article ID e3574.
Open this publication in new window or tab >>Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up
Show others...
2024 (English)In: Brain and Behavior, E-ISSN 2162-3279, Vol. 14, no 6, article id e3574Article in journal (Refereed) Published
Abstract [en]

Background: Olfactory dysfunction together with neurological and cognitive symptoms are common after COVID-19. We aimed to study whether performance on olfactory and neuropsychological tests following infection predict post-COVID condition (PCC), persisting symptoms, and reduced health-related quality of life.

Methods: Both hospitalized (N = 10) and non-hospitalized individuals (N = 56) were enrolled in this prospective cohort study. Participants were evaluated 1–3 months after infection with an olfactory threshold test and neuropsychological tests, which was used as predictors of PCC. A questionnaire outlining persisting symptoms and the validated instrument EuroQol five-dimension five-level for health-related quality of life assessment were used as outcome data 1 year after infection (N = 59). Principal component analysis was used to identify relevant predictors for PCC at 1 year.

Results: Objectively assessed olfactory dysfunction at 1–3 months post infection, but not subjective olfactory symptoms, predicted post-COVID condition with reduced health-related quality of life (PCC+) at 1 year. The PCC+ group scored more often below the cut off for mild cognitive impairment on the Montreal Cognitive Assessment (61.5% vs. 21.7%) and higher on the Multidimensional Fatigue Inventory-20, compared to the group without PCC+.

Conclusion: Our results indicate that objectively assessed, olfactory dysfunction is a predictor for PCC+. These findings underscore the importance of objective olfactory testing. We propose that olfactory screening in the early post-acute phase of COVID-19 infection might identify individuals that are at higher risk of developing long-term health sequalae.

Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
COVID-19, health-related quality of life, long covid, olfactory dysfunction, post-COVID condition (PCC)
National Category
Psychology (excluding Applied Psychology) Neurosciences
Identifiers
urn:nbn:se:umu:diva-226169 (URN)10.1002/brb3.3574 (DOI)001239804900001 ()38841730 (PubMedID)2-s2.0-85195270158 (Scopus ID)
Funder
Swedish Research Council, 2020-06235Swedish Research Council, 2016-06514Swedish Heart Lung Foundation, 20210078Swedish Heart Lung Foundation, 20200325Knut and Alice Wallenberg Foundation, VC-2020-0015Knut and Alice Wallenberg Foundation, FS2.1.6-849-20Knut and Alice Wallenberg Foundation, VLL 1925-2017Region Västerbotten, RV-939393Region Västerbotten, RV-938855
Available from: 2024-06-18 Created: 2024-06-18 Last updated: 2025-04-24Bibliographically approved
van Essen, T. A., van Erp, I. A., Lingsma, H. F., Pisică, D., Yue, J. K., Singh, R. D., . . . Peul, W. C. (2023). Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI): an observational cohort study. eClinicalMedicine, 63, Article ID 102161.
Open this publication in new window or tab >>Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI): an observational cohort study
Show others...
2023 (English)In: eClinicalMedicine, E-ISSN 2589-5370, Vol. 63, article id 102161Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Limited evidence existed on the comparative effectiveness of decompressive craniectomy (DC) versus craniotomy for evacuation of traumatic acute subdural hematoma (ASDH) until the recently published randomised clinical trial RESCUE-ASDH. In this study, that ran concurrently, we aimed to determine current practice patterns and compare outcomes of primary DC versus craniotomy.

METHODS: We conducted an analysis of centre treatment preference within the prospective, multicentre, observational Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (known as CENTER-TBI) and NeuroTraumatology Quality Registry (known as Net-QuRe) studies, which enrolled patients throughout Europe and Israel (2014-2020). We included patients with an ASDH who underwent acute neurosurgical evacuation. Patients with severe pre-existing neurological disorders were excluded. In an instrumental variable analysis, we compared outcomes between centres according to treatment preference, measured by the case-mix adjusted proportion DC per centre. The primary outcome was functional outcome rated by the 6-months Glasgow Outcome Scale Extended, estimated with ordinal regression as a common odds ratio (OR), adjusted for prespecified confounders. Variation in centre preference was quantified with the median odds ratio (MOR). CENTER-TBI is registered with ClinicalTrials.gov, number NCT02210221, and the Resource Identification Portal (Research Resource Identifier SCR_015582).

FINDINGS: Between December 19, 2014 and December 17, 2017, 4559 patients with traumatic brain injury were enrolled in CENTER-TBI of whom 336 (7%) underwent acute surgery for ASDH evacuation; 91 (27%) underwent DC and 245 (63%) craniotomy. The proportion primary DC within total acute surgery cases ranged from 6 to 67% with an interquartile range (IQR) of 12-26% among 46 centres; the odds of receiving a DC for prognostically similar patients in one centre versus another randomly selected centre were trebled (adjusted median odds ratio 2.7, p < 0.0001). Higher centre preference for DC over craniotomy was not associated with better functional outcome (adjusted common odds ratio (OR) per 14% [IQR increase] more DC in a centre = 0.9 [95% CI 0.7-1.1], n = 200). Primary DC was associated with more follow-on surgeries and complications [secondary cranial surgery 27% vs. 18%; shunts 11 vs. 5%]; and similar odds of in-hospital mortality (adjusted OR per 14% IQR more primary DC 1.3 [95% CI (1.0-3.4), n = 200]).

INTERPRETATION: We found substantial practice variation in the employment of DC over craniotomy for ASDH. This variation in treatment strategy did not result in different functional outcome. These findings suggest that primary DC should be restricted to salvageable patients in whom immediate replacement of the bone flap is not possible due to intraoperative brain swelling.

FUNDING: Hersenstichting Nederland for the Dutch NeuroTraumatology Quality Registry and the European Union Seventh Framework Program.

Place, publisher, year, edition, pages
Elsevier, 2023
Keywords
Acute subdural hematoma, Comparative effectiveness research, Craniotomy, Decompressive craniectomy, Instrumental variable analysis, Practice variation
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:umu:diva-221574 (URN)10.1016/j.eclinm.2023.102161 (DOI)001063167900001 ()37600483 (PubMedID)2-s2.0-85167581191 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme, 602150
Available from: 2024-02-27 Created: 2024-02-27 Last updated: 2024-02-28Bibliographically approved
Riemann, L., Mikolic, A., Maas, A., Unterberg, A. & Younsi, A. (2023). Computed tomography lesions and their association with global outcome in young people with mild traumatic brain injury. Journal of Neurotrauma, 40(11-12), 1243-1254
Open this publication in new window or tab >>Computed tomography lesions and their association with global outcome in young people with mild traumatic brain injury
Show others...
2023 (English)In: Journal of Neurotrauma, ISSN 0897-7151, E-ISSN 1557-9042, Vol. 40, no 11-12, p. 1243-1254Article in journal (Refereed) Published
Abstract [en]

Mild traumatic brain injury (mTBI) can be accompanied by structural damage to the brain. Here, we investigated how the presence of intracranial traumatic computed tomography (CT) pathologies relates to the global functional outcome in young patients one year after mTBI. All patients with mTBI (Glasgow Coma Scale: 13-15) ≤24 years in the multi-center, prospective, observational Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study were included. Patient demographics and CT findings were assessed at admission, and the Glasgow Outcome Scale Extended (GOSE) was evaluated at 12 months follow-up. The association between a "positive CT" (at least one of the following: epidural hematoma, subdural hematoma, traumatic subarachnoid hemorrhage (tSAH), intraventricular hemorrhage, subdural collection mixed density, contusion, traumatic axonal injury) and functional outcome (GOSE) was assessed using multi-variable mixed ordinal and logistic regression models. A total of 462 patients with mTBI and initial brain CT from 46 study centers were included. The median age was 19 (17-22) years, and 322 (70%) were males. CT imaging showed a traumatic intracranial pathology in 171 patients (37%), most commonly tSAH (48%), contusions (40%), and epidural hematomas (37%). Patients with a positive CT scan were less likely to achieve a complete recovery 12 months post-injury. The presence of any CT abnormality was associated with both lower GOSE scores (odds ratio [OR]: 0.39 [0.24-0.63]) and incomplete recovery (GOSE <8; OR: 0.41 [0.25-0.68]), also when adjusted for demographical and clinical baseline factors. The presence of intracranial traumatic CT pathologies was predictive of outcome 12 months after mTBI in young patients, which might help to identify candidates for early follow-up and additional care.

Place, publisher, year, edition, pages
Mary Ann Liebert, 2023
Keywords
CT findings, adolescents, children, intracranial lesions, mild TBI, outcome
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:umu:diva-221575 (URN)10.1089/neu.2022.0055 (DOI)000938494700001 ()36578216 (PubMedID)2-s2.0-85160968721 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme, 602150
Available from: 2024-02-27 Created: 2024-02-27 Last updated: 2024-02-28Bibliographically approved
Zickerman, C., Brorsson, C., Hultin, M., Johansson, G., Winsö, O. & Haney, M. (2023). Preoperative anxiety level is not associated with postoperative negative behavioral changes in premedicated children. Acta Anaesthesiologica Scandinavica, 67(6), 706-713
Open this publication in new window or tab >>Preoperative anxiety level is not associated with postoperative negative behavioral changes in premedicated children
Show others...
2023 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 67, no 6, p. 706-713Article in journal (Refereed) Published
Abstract [en]

Background: Anesthesia preinduction anxiety in children can according to some studies lead to long-term anxiety and negative behavioral changes (NBC), while other studies have not found this effect. This secondary analysis from a recent premedication trial comparing clonidine and midazolam aimed to test the relation between preoperative anxiety assessed with modified Yale Preoperative Anxiety Scale (mYPAS) and postoperative NBCs assessed with Post Hospital Behavior Questionnaire (PHBQ), regardless of premedication type.

Methods: This is a planned secondary analysis from a published premedication comparison trial in an outpatient surgery cohort, children aged 2–7 years. Participant and preoperative factors, particularly preoperative anxiety as mYPAS scores, were assessed for association with development of postoperative NBCs.

Results: Fifty-four of the 115 participants had high preinduction anxiety (mYPAS >30), and 19 of 115 developed >3 postoperative NBCs 1 week after surgery. There was no association between preinduction anxiety level as mYPAS scores and the development of postoperative NBCs at 1 week after surgery (10 of 19 had both, p =.62) nor after 4- or 26-weeks post-surgery. Only lower age was associated with development of NBCs postoperatively.

Conclusions: Based on the findings from this cohort, high preinduction anxiety does not appear to be associated with NBCs postoperatively in children premedicated with clonidine or midazolam.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
Keywords
children, postoperative negative behavioral changes, postoperative recovery, preoperative anxiety
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:umu:diva-206762 (URN)10.1111/aas.14240 (DOI)000962252500001 ()36928794 (PubMedID)2-s2.0-85151972127 (Scopus ID)
Funder
Umeå UniversityRegion Västerbotten
Available from: 2023-05-02 Created: 2023-05-02 Last updated: 2023-12-05Bibliographically approved
Mikolić, A., Steyerberg, E. W., Polinder, S., Wilson, L., Zeldovich, M., von Steinbuechel, N., . . . van Klaveren, D. (2023). Prognostic models for global functional outcome and post-concussion symptoms following mild traumatic brain injury: a collaborative european neurotrauma effectiveness research in traumatic brain injury (CENTER-TBI) study. Journal of Neurotrauma, 40(15-16), 1651-1670
Open this publication in new window or tab >>Prognostic models for global functional outcome and post-concussion symptoms following mild traumatic brain injury: a collaborative european neurotrauma effectiveness research in traumatic brain injury (CENTER-TBI) study
Show others...
2023 (English)In: Journal of Neurotrauma, ISSN 0897-7151, E-ISSN 1557-9042, Vol. 40, no 15-16, p. 1651-1670Article in journal (Refereed) Published
Abstract [en]

After mild traumatic brain injury (mTBI), a substantial proportion of individuals do not fully recover on the Glasgow Outcome Scale Extended (GOSE) or experience persistent post-concussion symptoms (PPCS). We aimed to develop prognostic models for the GOSE and PPCS at 6 months after mTBI and to assess the prognostic value of different categories of predictors (clinical variables; questionnaires; computed tomography [CT]; blood biomarkers). From the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, we included participants aged 16 or older with Glasgow Coma Score (GCS) 13-15. We used ordinal logistic regression to model the relationship between predictors and the GOSE, and linear regression to model the relationship between predictors and the Rivermead Post-concussion Symptoms Questionnaire (RPQ) total score. First, we studied a pre-specified Core model. Next, we extended the Core model with other clinical and sociodemographic variables available at presentation (Clinical model). The Clinical model was then extended with variables assessed before discharge from hospital: early post-concussion symptoms, CT variables, biomarkers, or all three categories (extended models). In a subset of patients mostly discharged home from the emergency department, the Clinical model was extended with 2-3-week post-concussion and mental health symptoms. Predictors were selected based on Akaike's Information Criterion. Performance of ordinal models was expressed as a concordance index (C) and performance of linear models as proportion of variance explained (R2). Bootstrap validation was used to correct for optimism. We included 2376 mTBI patients with 6-month GOSE and 1605 patients with 6-month RPQ. The Core and Clinical models for GOSE showed moderate discrimination (C = 0.68 95% confidence interval 0.68 to 0.70 and C = 0.70[0.69 to 0.71], respectively) and injury severity was the strongest predictor. The extended models had better discriminative ability (C = 0.71[0.69 to 0.72] with early symptoms; 0.71[0.70 to 0.72] with CT variables or with blood biomarkers; 0.72[0.71 to 0.73] with all three categories). The performance of models for RPQ was modest (R2 = 4% Core; R2 = 9% Clinical), and extensions with early symptoms increased the R2 to 12%. The 2-3-week models had better performance for both outcomes in the subset of participants with these symptoms measured (C = 0.74 [0.71 to 0.78] vs. C = 0.63[0.61 to 0.67] for GOSE; R2 = 37% vs. 6% for RPQ). In conclusion, the models based on variables available before discharge have moderate performance for the prediction of GOSE and poor performance for the prediction of PPCS. Symptoms assessed at 2-3 weeks are required for better predictive ability of both outcomes. The performance of the proposed models should be examined in independent cohorts.

Place, publisher, year, edition, pages
Mary Ann Liebert, 2023
Keywords
biomarkers, Glasgow Outcome Scale Extended, mild traumatic brain injury, post-concussion symptoms, predictors, prognostic model
National Category
Neurology
Identifiers
urn:nbn:se:umu:diva-216232 (URN)10.1089/neu.2022.0320 (DOI)000993931100001 ()37078144 (PubMedID)2-s2.0-85168315877 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme, 602150
Available from: 2023-11-06 Created: 2023-11-06 Last updated: 2023-11-06Bibliographically approved
Kals, M., Kunzmann, K., Parodi, L., Radmanesh, F., Wilson, L., Izzy, S., . . . Menon, D. K. (2022). A genome-wide association study of outcome from traumatic brain injury. EBioMedicine, 77, Article ID 103933.
Open this publication in new window or tab >>A genome-wide association study of outcome from traumatic brain injury
Show others...
2022 (English)In: EBioMedicine, E-ISSN 2352-3964, Vol. 77, article id 103933Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Factors such as age, pre-injury health, and injury severity, account for less than 35% of outcome variability in traumatic brain injury (TBI). While some residual outcome variability may be attributable to genetic factors, published candidate gene association studies have often been underpowered and subject to publication bias.

METHODS: We performed the first genome- and transcriptome-wide association studies (GWAS, TWAS) of genetic effects on outcome in TBI. The study population consisted of 5268 patients from prospective European and US studies, who attended hospital within 24 h of TBI, and satisfied local protocols for computed tomography.

FINDINGS: The estimated heritability of TBI outcome was 0·26. GWAS revealed no genetic variants with genome-wide significance (p < 5 × 10-8), but identified 83 variants in 13 independent loci which met a lower pre-specified sub-genomic statistical threshold (p < 10-5). Similarly, none of the genes tested in TWAS met tissue-wide significance. An exploratory analysis of 75 published candidate variants associated with 28 genes revealed one replicable variant (rs1800450 in the MBL2 gene) which retained significance after correction for multiple comparison (p = 5·24 × 10-4).

INTERPRETATION: While multiple novel loci reached less stringent thresholds, none achieved genome-wide significance. The overall heritability estimate, however, is consistent with the hypothesis that common genetic variation substantially contributes to inter-individual variability in TBI outcome. The meta-analytic approach to the GWAS and the availability of summary data allows for a continuous extension with additional cohorts as data becomes available.

FUNDING: A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

Place, publisher, year, edition, pages
Elsevier, 2022
Keywords
Consortia, Genome-Wide association study, Outcome, Recovery, Traumatic brain injury
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:umu:diva-215813 (URN)10.1016/j.ebiom.2022.103933 (DOI)000795901400017 ()35301180 (PubMedID)2-s2.0-85126327411 (Scopus ID)
Available from: 2023-10-26 Created: 2023-10-26 Last updated: 2023-10-27Bibliographically approved
Åkerlund, C. A. I., Holst, A., Stocchetti, N., Steyerberg, E. W., Menon, D. K., Ercole, A. & Nelson, D. W. (2022). Clustering identifies endotypes of traumatic brain injury in an intensive care cohort: a CENTER-TBI study. Critical Care, 26(1), Article ID 228.
Open this publication in new window or tab >>Clustering identifies endotypes of traumatic brain injury in an intensive care cohort: a CENTER-TBI study
Show others...
2022 (English)In: Critical Care, ISSN 1364-8535, E-ISSN 1466-609X, Vol. 26, no 1, article id 228Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: While the Glasgow coma scale (GCS) is one of the strongest outcome predictors, the current classification of traumatic brain injury (TBI) as 'mild', 'moderate' or 'severe' based on this fails to capture enormous heterogeneity in pathophysiology and treatment response. We hypothesized that data-driven characterization of TBI could identify distinct endotypes and give mechanistic insights.

METHODS: We developed an unsupervised statistical clustering model based on a mixture of probabilistic graphs for presentation (< 24 h) demographic, clinical, physiological, laboratory and imaging data to identify subgroups of TBI patients admitted to the intensive care unit in the CENTER-TBI dataset (N = 1,728). A cluster similarity index was used for robust determination of optimal cluster number. Mutual information was used to quantify feature importance and for cluster interpretation.

RESULTS: Six stable endotypes were identified with distinct GCS and composite systemic metabolic stress profiles, distinguished by GCS, blood lactate, oxygen saturation, serum creatinine, glucose, base excess, pH, arterial partial pressure of carbon dioxide, and body temperature. Notably, a cluster with 'moderate' TBI (by traditional classification) and deranged metabolic profile, had a worse outcome than a cluster with 'severe' GCS and a normal metabolic profile. Addition of cluster labels significantly improved the prognostic precision of the IMPACT (International Mission for Prognosis and Analysis of Clinical trials in TBI) extended model, for prediction of both unfavourable outcome and mortality (both p < 0.001).

CONCLUSIONS: Six stable and clinically distinct TBI endotypes were identified by probabilistic unsupervised clustering. In addition to presenting neurology, a profile of biochemical derangement was found to be an important distinguishing feature that was both biologically plausible and associated with outcome. Our work motivates refining current TBI classifications with factors describing metabolic stress. Such data-driven clusters suggest TBI endotypes that merit investigation to identify bespoke treatment strategies to improve care. 

Place, publisher, year, edition, pages
BioMed Central (BMC), 2022
Keywords
Critical care, Endotypes, Intensive care unit, Machine learning, Traumatic brain injury, Unsupervised clustering
National Category
Anesthesiology and Intensive Care Neurology
Identifiers
urn:nbn:se:umu:diva-221583 (URN)10.1186/s13054-022-04079-w (DOI)000831208500002 ()35897070 (PubMedID)2-s2.0-85135370588 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme
Available from: 2024-02-27 Created: 2024-02-27 Last updated: 2024-02-28Bibliographically approved
Volovici, V., Pisică, D., Gravesteijn, B. Y., Dirven, C. M. F., Steyerberg, E. W., Ercole, A., . . . Lingsma, H. F. (2022). Comparative effectiveness of intracranial hypertension management guided by ventricular versus intraparenchymal pressure monitoring: a CENTER-TBI study. Acta Neurochirurgica, 164(7), 1693-1705
Open this publication in new window or tab >>Comparative effectiveness of intracranial hypertension management guided by ventricular versus intraparenchymal pressure monitoring: a CENTER-TBI study
Show others...
2022 (English)In: Acta Neurochirurgica, ISSN 0001-6268, E-ISSN 0942-0940, Vol. 164, no 7, p. 1693-1705Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: To compare outcomes between patients with primary external ventricular device (EVD)-driven treatment of intracranial hypertension and those with primary intraparenchymal monitor (IP)-driven treatment.

METHODS: The CENTER-TBI study is a prospective, multicenter, longitudinal observational cohort study that enrolled patients of all TBI severities from 62 participating centers (mainly level I trauma centers) across Europe between 2015 and 2017. Functional outcome was assessed at 6 months and a year. We used multivariable adjusted instrumental variable (IV) analysis with "center" as instrument and logistic regression with covariate adjustment to determine the effect estimate of EVD on 6-month functional outcome.

RESULTS: A total of 878 patients of all TBI severities with an indication for intracranial pressure (ICP) monitoring were included in the present study, of whom 739 (84%) patients had an IP monitor and 139 (16%) an EVD. Patients included were predominantly male (74% in the IP monitor and 76% in the EVD group), with a median age of 46 years in the IP group and 48 in the EVD group. Six-month GOS-E was similar between IP and EVD patients (adjusted odds ratio (aOR) and 95% confidence interval [CI] OR 0.74 and 95% CI [0.36-1.52], adjusted IV analysis). The length of intensive care unit stay was greater in the EVD group than in the IP group (adjusted rate ratio [95% CI] 1.70 [1.34-2.12], IV analysis). One hundred eighty-seven of the 739 patients in the IP group (25%) required an EVD due to refractory ICPs.

CONCLUSION: We found no major differences in outcomes of patients with TBI when comparing EVD-guided and IP monitor-guided ICP management. In our cohort, a quarter of patients that initially received an IP monitor required an EVD later for ICP control. The prevalence of complications was higher in the EVD group.

Place, publisher, year, edition, pages
Springer, 2022
Keywords
CENTER-TBI, EVD, External ventricular devices, ICP, Intracranial hypertension, Intracranial pressure monitoring, Intraparenchymal monitors, Severe TBI, Traumatic brain injury
National Category
Anesthesiology and Intensive Care Neurology Surgery
Identifiers
urn:nbn:se:umu:diva-221585 (URN)10.1007/s00701-022-05257-z (DOI)000804526800001 ()35648213 (PubMedID)2-s2.0-85131406979 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme
Available from: 2024-02-27 Created: 2024-02-27 Last updated: 2024-02-28Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-2113-8098

Search in DiVA

Show all publications